The COVID-19 pandemic has fundamentally reshaped the diagnostics landscape in Europe. With major countries like the United Kingdom and France conducting over 112 million and 58 million tests, respectively (as of March 2021), the Europe COVID-19 diagnostics market has seen unprecedented growth. According to Expert Market Research, the region continues to witness demand for advanced, scalable, and accurate testing technologies to detect SARS-CoV-2 infections.
Europe COVID-19 Diagnostics Market Share
The European diagnostics market has seen significant contributions from both global and regional diagnostic companies. The PCR test segment has dominated due to its high sensitivity and accuracy, particularly in clinical and hospital settings. Countries like the UK, Germany, France, and Italy have led in testing volume and infrastructure deployment.
In terms of end-use, hospitals and diagnostic laboratories account for the largest share, with a notable rise in Point-of-Care (PoC) testing across community centers and pharmacies.
Europe COVID-19 Diagnostics Market Growth & Trends
Key Drivers of Growth:
Recurring infection waves and virus mutations increasing testing frequency
Widespread adoption of RT-PCR and antigen testing kits
Advancements in automated diagnostic platforms and home test kits
Government-funded mass testing initiatives and health campaigns
Emerging Trends:
Rise of rapid antigen testing for travel and workplace screening
Integration of AI-powered diagnostics for real-time results and population surveillance
Multiplex testing kits detecting both COVID-19 and influenza
Movement towards self-administered and over-the-counter tests, enhancing convenience and early detection
Per Wikipedia, COVID-19 testing plays a critical role in tracking virus spread, reducing transmission, and informing public health decisions.
Europe COVID-19 Diagnostics Market Case Studies & News
Primerdesign Ltd, a UK-based molecular diagnostics company, launched COVID-19 genesig® Real-Time PCR assay, one of the first CE-marked tests in Europe.
Genomica S.A.U, headquartered in Spain, partnered with healthcare networks to provide rapid molecular testing solutions during infection surges.
In Germany, Altona Diagnostics GmbH developed RealStar® SARS-CoV-2 RT-PCR Kit, widely used in hospitals and laboratories across the region.
BioMaxima SA introduced rapid antibody test kits for mass population screenings in Poland and Eastern Europe.
These case studies underscore Europe's diversified and responsive diagnostic ecosystem.
Europe COVID-19 Diagnostics Market Analysis
The market operates in a dynamic regulatory and demand-driven environment. The European Centre for Disease Prevention and Control (ECDC) and national healthcare agencies play pivotal roles in approving and deploying diagnostic tests under emergency protocols.
Competitive Landscape:
The market is moderately fragmented, with innovation-driven SMEs and larger IVD companies competing in terms of test sensitivity, turnaround time, and ease of use. The shift from centralized testing to PoC and decentralized testing models is reshaping competitive strategies.
Challenges:
Declining testing volumes post-pandemic peaks
Regulatory hurdles in updating test kits to new COVID-19 variants
Market saturation in certain regions due to overstock of diagnostic supplies
Europe COVID-19 Diagnostics Market Segmentation
By Test Type:
PCR Test
Antigen Test
Antibody Test
Others
By Product:
RT-PCR Assay Kits
Immunoassay Test Strips
Others
By Sample Type:
Nasopharyngeal Swab
Oropharyngeal (OP) Swab
Nasal Swab
Blood Test
Others
By Business Model:
Point-of-Care (PoC) Testing
Non-Point-of-Care (PoC) Testing
By End Use:
Hospitals
Diagnostic Centres and Clinics
Laboratories
Others
By Region:
United Kingdom
Germany
Italy
France
Spain
Others
Key Players in the Europe COVID-19 Diagnostics Market
Altona Diagnostics GmbH
Genomica S.A.U
Clonit srl
BioMaxima SA
Primerdesign Ltd
Others
These companies are driving innovation by focusing on faster processing times, variant detection, and expanding access to underserved regions.
Access More Reports
Artificial Insemination Market
Amyotrophic Lateral Sclerosis Market
About Us:
Expert Market Research is a leading market research firm delivering data-driven insights to the pharmaceutical, biotechnology, and medical device industries. Our comprehensive research solutions include market research reports, providing in-depth analysis of industry trends and competitive landscapes; drug pipeline reports, tracking drug development progress, clinical trials, and regulatory approvals; epidemiology reports, offering detailed disease prevalence and patient population studies; and patent reports, assessing intellectual property landscapes and innovation trends, among others.
Leveraging proprietary data, advanced analytics, and expert methodologies, we help businesses navigate complex markets, optimize strategies, and drive innovation. We empower clients with actionable intelligence, enabling them to make informed decisions and stay ahead in the rapidly evolving healthcare sector.
Media Contact:
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Digital Marketing
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
